AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Sitalembic M 1000mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Alembic Pharmaceuticals Ltd

Salt Composition

Sitagliptin (1000mg) + Metformin (500mg)

Overview Sitalembic M 1000mg/500mg Tablet

Duo-Control 1000mg/500mg tablets effectively manage elevated blood glucose in individuals with type 2 diabetes. This dual-action medication helps mitigate serious diabetic complications, such as vision impairment and kidney disease, and may lessen the risk of cardiovascular events. Duo-Control 1000mg/500mg tablets can be used as a standalone treatment or in conjunction with other diabetes therapies. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is personalized based on your health status, blood sugar readings, and current medications. Consuming the tablets with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes effectiveness; discontinuation should only occur under physician guidance. Adherence to your prescribed diet and exercise regimen is crucial for successful diabetes management. Common side effects include nausea, vomiting, diarrhea, stomach upset, headache, and sore throat. Hypoglycemia is a potential adverse effect, particularly when combined with insulin or sulfonylureas; learn to recognize and treat this condition. This medication isn't suitable for all patients. Inform your doctor of any pre-existing kidney, liver, heart, or pancreatic conditions, or significant alcohol consumption before commencing treatment. Pregnant or lactating individuals should seek medical counsel. Potential drug interactions exist; disclose all medications to your doctor to ensure safety. Alcohol should be avoided due to its potential to lower blood glucose. Your doctor will monitor your kidney function and blood sugar levels throughout your treatment.

Uses of Sitalembic M 1000mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Sitalembic M 1000mg/500mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Sitalembic M 1000mg/500mg tablets should be administered with a meal.

Common Side effects of Sitalembic M 1000mg/500mg Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitalembic M 1000mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Sitalembic M 1000mg/500mg Tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.

How Sitalembic M 1000mg/500mg Tablet works:

Sitalembic M, a 1000mg/500mg tablet, combines sitagliptin and metformin to manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and reduces hepatic glucose output. Metformin, a biguanide, decreases liver glucose production, slows intestinal glucose absorption, and augments insulin sensitivity. This dual action leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of alcohol and Sitalembic M 1000mg/500mg tablets is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sitalembic M 1000mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against potential hazards before recommending this medication. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Sitalembic M 1000mg/500mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Sitalembic M 1000mg/500mg Tablets, as dose modification may be necessary. Physician consultation is recommended. For individuals with severe kidney disease, Sitalembic M 1000mg/500mg Tablets are contraindicated. Routine monitoring of renal function is advised during treatment.

LiverLiverUNSAFE

Patients with liver disorders should likely avoid Sitalembic M 1000mg/500mg tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Sitalembic M 1000mg/500mg Tablet :

Should you forget a Sitalembic M 1000mg/500mg Tablet dose, ingest it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitalembic M 1000mg/500mg Tablet

LabelValue
Addictive None.
Type of Medication Medication for diabetes

FAQs on Sitalembic M 1000mg/500mg Tablet

Sitalembic M 1000mg/500mg tablets contain sitagliptin and metformin, working synergistically to manage type 2 diabetes mellitus in adults. This medication enhances glycemic control when combined with a healthy diet and regular physical activity. Metformin reduces hepatic glucose production and improves insulin responsiveness, while sitagliptin, by inhibiting DPP-4, stimulates increased pancreatic insulin secretion. This formulation is unsuitable for individuals under 18.
Sitalembic M 1000mg/500mg Tablet's prolonged use can indeed lead to Vitamin B12 deficiency by impeding its gastric absorption. This deficiency, if left unaddressed, may manifest as anemia and neurological complications, including paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive impairment, and ataxia. Preventive measures, as proposed by some studies, include annual supplemental Vitamin B12 intake.
Sitalembic M 1000mg/500mg Tablet may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but serious adverse reactions such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Patients with hypersensitivity to any Sitalembic M 1000mg/500mg Tablet ingredient or excipient should not take this medication. This medicine is contraindicated in individuals with severe renal or hepatic dysfunction, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Consuming alcohol concurrently with Sitalembic M 1000mg/500mg Tablet is unsafe due to the heightened risk of lactic acidosis.
Retain this medication in its original, sealed container. Follow the storage guidelines provided on the packaging. Discard any leftover medication. Prevent access by children, pets, and others.
Sitalembic M 1000mg/500mg Tablet use carries a risk of lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. This adverse reaction, also termed Metformin-associated lactic acidosis (MALA), is infrequent but necessitates caution. Consequently, its use is contraindicated in individuals with pre-existing kidney impairment, the elderly, or those consuming substantial alcohol. Symptoms potentially indicative of lactic acidosis include muscular aches or weakness, vertigo, fatigue, peripheral coldness, dyspnea, emesis, nausea, abdominal discomfort, and bradycardia. Should these symptoms develop, discontinue Sitalembic M and seek immediate medical attention.
The Sitalembic M 1000mg/500mg tablet combines sitagliptin and metformin to manage type 2 diabetes mellitus in adults. This medication enhances blood sugar control when used with a suitable diet and exercise program. Metformin reduces hepatic glucose production and improves insulin responsiveness. Sitagliptin's action involves DPP4 enzyme inhibition, thereby boosting pancreatic insulin secretion. This formulation is unsuitable for individuals under 18.
Sitalembic M 1000mg/500mg tablets may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis may occur. Prolonged use can result in vitamin B12 deficiency.
Patients with hypersensitivity to Sitalembic M 1000mg/500mg Tablet ingredients or inactive substances should not take this medication. Similarly, its use is contraindicated in individuals with severe renal or hepatic dysfunction, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitalembic M 1000mg/500mg Tablet and alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitalembic M 1000mg/500mg Tablet use carries a risk of lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. This adverse reaction, also termed Metformin-associated lactic acidosis (MALA), is infrequent but necessitates caution. Therefore, its use is contraindicated in individuals with pre-existing kidney impairment, advanced age, or significant alcohol consumption. Symptoms potentially indicating lactic acidosis include myalgia, weakness, vertigo, fatigue, peripheral coldness, dyspnea, nausea, emesis, abdominal discomfort, and bradycardia. Should these symptoms appear, discontinue Sitalembic M and seek immediate medical attention.
Prolonged Sitalembic M 1000mg/500mg Tablet use can indeed lead to Vitamin B12 deficiency. This medication impedes Vitamin B12 absorption within the gastrointestinal tract. Consequently, untreated deficiency may manifest as anemia and neurological complications, including peripheral paresthesia (tingling and numbness in the extremities), muscle weakness, urinary dysfunction, cognitive impairment, and ataxia. To mitigate these risks, supplemental Vitamin B12 intake, at a minimum, annually, is recommended by some studies.
Store this medication in its original, tightly sealed container or packaging. Follow the storage instructions provided on the packaging or label. Discard any leftover medication. Prevent access by children, pets, and others.
The medication Sitalembic M 1000mg/500mg Tablet combines sitagliptin and metformin to manage type 2 diabetes mellitus in adults. This treatment enhances blood sugar control when coupled with a healthy diet and regular physical activity. Metformin reduces glucose production by the liver and increases insulin sensitivity. Sitagliptin works by suppressing DPP4, thus boosting insulin secretion from the pancreas. This formulation is unsuitable for individuals under 18.
Sitalembic M 1000mg/500mg tablets may cause common adverse reactions including low blood glucose, taste disturbances, nausea, abdominal discomfort, diarrhea, headache, and upper respiratory infections. Rare but potentially serious side effects such as lactic acidosis may occur. Prolonged use can result in vitamin B12 deficiency.
Patients with hypersensitivity to any Sitalembic M 1000mg/500mg Tablet ingredient or inactive component should not use this medication. Its use is contraindicated in individuals experiencing severe renal or hepatic dysfunction, congestive cardiac failure, lactic acidosis, or diabetic ketoacidosis.
Consuming alcohol concurrently with Sitalembic M 1000mg/500mg tablets is unsafe due to a heightened risk of lactic acidosis.
Indeed, Sitalembic M 1000mg/500mg Tablet ingestion can result in lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed MALA (Metformin-associated lactic acidosis), this uncommon adverse reaction to metformin necessitates its avoidance in individuals with pre-existing kidney impairment, the elderly, or those consuming significant alcohol. Lactic acidosis symptoms might encompass muscle aches or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, emesis, abdominal pain, or bradycardia. Should these symptoms arise, discontinue Sitalembic M and seek immediate medical attention.
Prolonged use of Sitalembic M 1000mg/500mg Tablets can lead to Vitamin B12 deficiency. This medication impedes Vitamin B12 absorption in the gastrointestinal tract. Untreated deficiency may result in anemia and neurological complications, potentially manifesting as paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive changes, and gait instability. To mitigate these risks, supplemental Vitamin B12 is recommended by some studies at least annually.
Store this medication in its original, tightly sealed container, following the storage directions on the packaging. Discard any remaining medication after use. Prevent access by children, pets, and other individuals.
Sitalembic M 1000mg/500mg...
168
MRP 195
13% off